OnKure Therapeutics
Develops mutation-selective PI3Kα medicines for cancer and vascular anomalies.
$3.79
After-hours close0.00 (0.00%)
At close$3.79(−1.04%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.36 | — | — |
| Aug 2026 | −$0.54 | −$0.31 | +42.1% |
| May 2026 | −$0.81 | −$1.11 | −37.0% |
| Mar 2026 | −$1.15 | −$0.99 | +13.9% |
| Nov 2025 | −$1.20 | −$1.09 | +9.2% |
The latest year is open to everyone — the 12 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.36 | — | — | $166.7K | — | — |
| Aug 4, 2026 | −$0.54 | −$0.31 | +42.1% | $166.7K | — | — |
| May 5, 2026 | −$0.81 | −$1.11 | −37.0% | $166.7K | — | — |
| Mar 12, 2026 | −$1.15 | −$0.99 | +13.9% | $16.0M | — | — |
| Nov 6, 2025 | −$1.20 | −$1.09 | +9.2% | — | — | — |
The latest year is open to everyone — the 12 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 6, 2025 | ||||||
| Mar 10, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 7, 2024 | ||||||
| Dec 31, 2023 | ||||||
| Sep 30, 2023 | ||||||
| Jun 30, 2023 | ||||||
| Mar 31, 2023 | ||||||
| Mar 27, 2023 | ||||||
| Nov 8, 2022 | ||||||